Incremental costs of fragility fractures: a population-based matched -cohort study from Ontario, Canada

• Published in: Osteoporosis international 2021-09, Vol.32 (9), p.1753-1761
• Main Authors: Tarride, J.-É., Adachi, J. D., Brown, J. P., Schemitsch, E., Slatkovska, L., Burke, N.
• Format: Article
• Language: English
• Subjects: Aged; Aging; Cohort analysis; Cohort Studies; Costs; Drug Costs; Endocrinology; Femur; Fractures; Humans; Medicine; Medicine & Public Health; Ontario - epidemiology; Original; Original Article; Orthopedics; Osteoporosis; Osteoporotic Fractures - epidemiology; Patients; Population studies; Population-based studies; Resource utilization; Retrospective Studies; Rheumatology
• ISSN: 0937-941X; 1433-2965
• DOI: 10.1007/s00198-021-05877-8

Summary Using a matched cohort design, the 1-year excess cost of incident fragility fractures at any site was $26,341 per patient, with 43% of total excess costs attributed to hospitalization. The high economic burden of fractures in Ontario underscores the urgency of closing the secondary fracture prevention gap. Introduction This retrospective real-world observational study was conducted to document the incremental costs associated with fragility fractures in Ontario, Canada. Methods Patients aged >65 years with an index fragility fracture occurring between January 2011 and March 2015 were identified from administrative databases and matched 1:1 to a cohort of similar patients without a fracture. Healthcare resource utilization data were extracted from healthcare records and associated costs were calculated on a per-patient level and for the province of Ontario. Costs were presented as 2017 Canadian dollars. Results The eligible cohort included 115,776 patients with a fragility fracture. Of these, 101,773 patients were successfully matched 1:1 to a non-fracture cohort. Overall, hip fractures ( n = 31,613) were the most common, whereas femur fractures ( n = 3002) were the least common type. Hospitalization and continuing care/home care/long-term care accounted for more than 60% of 1-year direct costs, whereas 5% was attributed to medication costs. First-year costs per patient in the fracture cohort were approximately threefold higher versus the non-fracture cohort (mean $37,362 versus $11,020, respectively). The incremental first-year direct healthcare costs of fragility fractures for the province of Ontario were calculated at $724 million per year. Conclusions Fragility fractures were associated with a threefold increase in overall mean healthcare costs per patient compared to patients without fractures. With an aging population, there is an urgent need for improved prevention strategies for patients at high-risk of fracture to decrease the economic burden of fragility fractures on the Canadian healthcare system.